x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
77-0207692
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
Large accelerated filer
x
|
Accelerated filer
o
|
Non-accelerated filer
o
|
Smaller reporting company
o
|
Emerging growth company
o
|
|
|
(Do not check if a smaller reporting company)
|
|
|
PART I. FINANCIAL INFORMATION
|
Page No.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PART II. OTHER INFORMATION
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Revenues
(in millions)
|
Operating Income
(in millions)
|
|
|
Three Months Ended
|
|
|
|
Six Months Ended
|
|
|
||||||||||||||||||||||
|
|
September 30,
|
|
Increase
|
|
September 30,
|
|
Increase
|
||||||||||||||||||||||
(in thousands, except percentages)
|
|
2016
|
|
2017
|
|
(Decrease)
|
|
2016
|
|
2017
|
|
(Decrease)
|
||||||||||||||||||
Net revenues
|
|
$
|
216,183
|
|
|
$
|
210,300
|
|
|
$
|
(5,883
|
)
|
|
(2.7
|
)%
|
|
$
|
439,289
|
|
|
$
|
414,226
|
|
|
$
|
(25,063
|
)
|
|
(5.7
|
)%
|
Cost of revenues
|
|
105,737
|
|
|
102,668
|
|
|
(3,069
|
)
|
|
(2.9
|
)%
|
|
215,770
|
|
|
203,311
|
|
|
(12,459
|
)
|
|
(5.8
|
)%
|
||||||
Gross profit
|
|
$
|
110,446
|
|
|
$
|
107,632
|
|
|
$
|
(2,814
|
)
|
|
(2.5
|
)%
|
|
$
|
223,519
|
|
|
$
|
210,915
|
|
|
$
|
(12,604
|
)
|
|
(5.6
|
)%
|
Gross profit %
|
|
51.1
|
%
|
|
51.2
|
%
|
|
|
|
|
|
|
50.9
|
%
|
|
50.9
|
%
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Six Months Ended
|
|
|
||||||||||||||||||||||
|
|
September 30,
|
|
Increase
|
|
September 30,
|
|
Increase
|
||||||||||||||||||||||
(in thousands, except percentages)
|
|
2016
|
|
2017
|
|
(Decrease)
|
|
2016
|
|
2017
|
|
(Decrease)
|
||||||||||||||||||
Research, development, and engineering
|
|
$
|
22,379
|
|
|
$
|
19,932
|
|
|
$
|
(2,447
|
)
|
|
(10.9
|
)%
|
|
$
|
44,723
|
|
|
$
|
41,145
|
|
|
$
|
(3,578
|
)
|
|
(8.0
|
)%
|
% of net revenues
|
|
10.4
|
%
|
|
9.5
|
%
|
|
|
|
|
|
10.2
|
%
|
|
9.9
|
%
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Six Months Ended
|
|
|
||||||||||||||||||||||
|
|
September 30,
|
|
Increase
|
|
September 30,
|
|
Increase
|
||||||||||||||||||||||
(in thousands, except percentages)
|
|
2016
|
|
2017
|
|
(Decrease)
|
|
2016
|
|
2017
|
|
(Decrease)
|
||||||||||||||||||
Selling, general, and administrative
|
|
$
|
56,875
|
|
|
$
|
57,696
|
|
|
$
|
821
|
|
|
1.4
|
%
|
|
$
|
112,662
|
|
|
$
|
113,929
|
|
|
$
|
1,267
|
|
|
1.1
|
%
|
% of net revenues
|
|
26.3
|
%
|
|
27.4
|
%
|
|
|
|
|
|
|
25.6
|
%
|
|
27.5
|
%
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Six Months Ended
|
|
|
||||||||||||||||||||||
|
|
September 30,
|
|
Increase
|
|
September 30,
|
|
Increase
|
||||||||||||||||||||||
(in thousands, except percentages)
|
|
2016
|
|
2017
|
|
(Decrease)
|
|
2016
|
|
2017
|
|
(Decrease)
|
||||||||||||||||||
(Gain) loss, net from litigation settlements
|
|
$
|
(349
|
)
|
|
$
|
(104
|
)
|
|
$
|
245
|
|
|
(70.2
|
)%
|
|
$
|
4,390
|
|
|
$
|
(280
|
)
|
|
$
|
(4,670
|
)
|
|
(106.4
|
)%
|
% of net revenues
|
|
0.2
|
%
|
|
—
|
%
|
|
|
|
|
|
1.0
|
%
|
|
(0.1
|
)%
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Six Months Ended
|
|
|
||||||||||||||||||||||
|
|
September 30,
|
|
Increase
|
|
September 30,
|
|
Increase
|
||||||||||||||||||||||
(in thousands, except percentages)
|
|
2016
|
|
2017
|
|
(Decrease)
|
|
2016
|
|
2017
|
|
(Decrease)
|
||||||||||||||||||
Restructuring and other related charges (credits)
|
|
$
|
(415
|
)
|
|
$
|
(51
|
)
|
|
$
|
364
|
|
|
(87.7
|
)%
|
|
$
|
(1,463
|
)
|
|
$
|
2,522
|
|
|
$
|
3,985
|
|
|
(272.4
|
)%
|
% of net revenues
|
|
0.2
|
%
|
|
—
|
%
|
|
|
|
|
|
(0.3
|
)%
|
|
0.6
|
%
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
Six Months Ended
|
|
|
||||||||||||||||||||||
|
|
September 30,
|
|
Increase
|
|
September 30,
|
|
Increase
|
||||||||||||||||||||||
(in thousands, except percentages)
|
|
2016
|
|
2017
|
|
(Decrease)
|
|
2016
|
|
2017
|
|
(Decrease)
|
||||||||||||||||||
Other non-operating income and (expense), net
|
|
$
|
1,340
|
|
|
$
|
1,826
|
|
|
$
|
486
|
|
|
36.3
|
%
|
|
$
|
3,692
|
|
|
$
|
2,740
|
|
|
$
|
(952
|
)
|
|
(25.8
|
)%
|
% of net revenues
|
|
0.6
|
%
|
|
0.9
|
%
|
|
|
|
|
|
0.8
|
%
|
|
0.7
|
%
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
|
Six Months Ended
|
|
|
|
|
||||||||||||||||||
|
|
September 30,
|
|
Increase
|
|
September 30,
|
|
Increase
|
||||||||||||||||||||||
(in thousands except percentages)
|
|
2016
|
|
2017
|
|
(Decrease)
|
|
2016
|
|
2017
|
|
(Decrease)
|
||||||||||||||||||
Income before income taxes
|
|
$
|
26,039
|
|
|
$
|
24,725
|
|
|
$
|
(1,314
|
)
|
|
(5.0
|
)%
|
|
$
|
52,354
|
|
|
$
|
41,776
|
|
|
$
|
(10,578
|
)
|
|
(20.2
|
)%
|
Income tax expense
|
|
5,565
|
|
|
4,772
|
|
|
(793
|
)
|
|
(14.2
|
)%
|
|
11,493
|
|
|
2,995
|
|
|
(8,498
|
)
|
|
(73.9
|
)%
|
||||||
Net income
|
|
$
|
20,474
|
|
|
$
|
19,953
|
|
|
$
|
(521
|
)
|
|
(2.5
|
)%
|
|
$
|
40,861
|
|
|
$
|
38,781
|
|
|
$
|
(2,080
|
)
|
|
(5.1
|
)%
|
Effective tax rate
|
|
21.4
|
%
|
|
19.3
|
%
|
|
|
|
|
|
|
22.0
|
%
|
|
7.2
|
%
|
|
|
|
|
Operating Cash Flow
(in millions)
|
Investing Cash Flow
(in millions)
|
Financing Cash Flow
(in millions)
|
•
|
maximum ratio of funded debt to earnings before interest, taxes, depreciation and amortization ("EBITDA") of 3.25:1 (previously 3:1); and
|
•
|
minimum EBITDA coverage ratio, which is calculated as interest payments divided by EBITDA.
|
|
March 31,
2017 |
|
September 30,
2017 |
||||
ASSETS
|
|
|
|
||||
Current assets:
|
|
|
|
||||
Cash and cash equivalents
|
$
|
301,970
|
|
|
$
|
303,116
|
|
Short-term investments
|
178,179
|
|
|
197,278
|
|
||
Accounts receivable, net
|
141,177
|
|
|
139,683
|
|
||
Inventory, net
|
55,456
|
|
|
60,999
|
|
||
Other current assets
|
22,195
|
|
|
33,310
|
|
||
Total current assets
|
698,977
|
|
|
734,386
|
|
||
Long-term investments
|
127,176
|
|
|
105,251
|
|
||
Property, plant, and equipment, net
|
150,307
|
|
|
146,830
|
|
||
Goodwill and purchased intangibles, net
|
15,577
|
|
|
15,498
|
|
||
Deferred tax and other assets
|
25,122
|
|
|
20,417
|
|
||
Total assets
|
$
|
1,017,159
|
|
|
$
|
1,022,382
|
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS' EQUITY
|
|
|
|
|
|
||
Current liabilities:
|
|
|
|
|
|
||
Accounts payable
|
$
|
42,885
|
|
|
$
|
45,619
|
|
Accrued liabilities
|
74,285
|
|
|
68,434
|
|
||
Total current liabilities
|
117,170
|
|
|
114,053
|
|
||
Long term debt, net of issuance costs
|
491,059
|
|
|
491,784
|
|
||
Long-term income taxes payable
|
11,729
|
|
|
11,997
|
|
||
Other long-term liabilities
|
15,045
|
|
|
16,881
|
|
||
Total liabilities
|
$
|
635,003
|
|
|
$
|
634,715
|
|
Commitments and contingencies (Note 6)
|
|
|
|
|
|
||
Stockholders' equity:
|
|
|
|
|
|
||
Common stock
|
$
|
804
|
|
|
$
|
813
|
|
Additional paid-in capital
|
818,777
|
|
|
848,729
|
|
||
Accumulated other comprehensive income
|
4,694
|
|
|
1,531
|
|
||
Retained earnings
|
319,931
|
|
|
348,655
|
|
||
Total stockholders' equity before treasury stock
|
1,144,206
|
|
|
1,199,728
|
|
||
Less: Treasury stock, at cost
|
(762,050
|
)
|
|
(812,061
|
)
|
||
Total stockholders' equity
|
382,156
|
|
|
387,667
|
|
||
Total liabilities and stockholders' equity
|
$
|
1,017,159
|
|
|
$
|
1,022,382
|
|
|
Three Months Ended
September 30, |
|
Six Months Ended
September 30, |
||||||||||||
|
2016
|
|
2017
|
|
2016
|
|
2017
|
||||||||
Net revenues
|
$
|
216,183
|
|
|
$
|
210,300
|
|
|
$
|
439,289
|
|
|
$
|
414,226
|
|
Cost of revenues
|
105,737
|
|
|
102,668
|
|
|
215,770
|
|
|
203,311
|
|
||||
Gross profit
|
110,446
|
|
|
107,632
|
|
|
223,519
|
|
|
210,915
|
|
||||
Operating expenses:
|
|
|
|
|
|
|
|
||||||||
Research, development, and engineering
|
22,379
|
|
|
19,932
|
|
|
44,723
|
|
|
41,145
|
|
||||
Selling, general, and administrative
|
56,875
|
|
|
57,696
|
|
|
112,662
|
|
|
113,929
|
|
||||
(Gain) loss, net from litigation settlements
|
(349
|
)
|
|
(104
|
)
|
|
4,390
|
|
|
(280
|
)
|
||||
Restructuring and other related charges (credits)
|
(415
|
)
|
|
(51
|
)
|
|
(1,463
|
)
|
|
2,522
|
|
||||
Total operating expenses
|
78,490
|
|
|
77,473
|
|
|
160,312
|
|
|
157,316
|
|
||||
Operating income
|
31,956
|
|
|
30,159
|
|
|
63,207
|
|
|
53,599
|
|
||||
Interest expense
|
(7,257
|
)
|
|
(7,260
|
)
|
|
(14,545
|
)
|
|
(14,563
|
)
|
||||
Other non-operating income and (expense), net
|
1,340
|
|
|
1,826
|
|
|
3,692
|
|
|
2,740
|
|
||||
Income before income taxes
|
26,039
|
|
|
24,725
|
|
|
52,354
|
|
|
41,776
|
|
||||
Income tax expense
|
5,565
|
|
|
4,772
|
|
|
11,493
|
|
|
2,995
|
|
||||
Net income
|
$
|
20,474
|
|
|
$
|
19,953
|
|
|
$
|
40,861
|
|
|
$
|
38,781
|
|
|
|
|
|
|
|
|
|
||||||||
Earnings per common share:
|
|
|
|
|
|
|
|
||||||||
Basic
|
$
|
0.63
|
|
|
$
|
0.59
|
|
|
$
|
1.27
|
|
|
$
|
1.16
|
|
Diluted
|
$
|
0.63
|
|
|
$
|
0.59
|
|
|
$
|
1.24
|
|
|
$
|
1.14
|
|
|
|
|
|
|
|
|
|
||||||||
Shares used in computing earnings per common share:
|
|
|
|
|
|
|
|
||||||||
Basic
|
32,281
|
|
|
32,570
|
|
|
32,269
|
|
|
32,538
|
|
||||
Diluted
|
32,726
|
|
|
32,809
|
|
|
32,865
|
|
|
33,111
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Cash dividends declared per common share
|
$
|
0.15
|
|
|
$
|
0.15
|
|
|
$
|
0.30
|
|
|
$
|
0.30
|
|
|
Three Months Ended
September 30, |
|
Six Months Ended
September 30, |
||||||||||||
|
2016
|
|
2017
|
|
2016
|
|
2017
|
||||||||
Net income
|
$
|
20,474
|
|
|
$
|
19,953
|
|
|
$
|
40,861
|
|
|
$
|
38,781
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
|
||||||||
Foreign currency translation adjustments
|
4
|
|
|
57
|
|
|
(250
|
)
|
|
257
|
|
||||
Unrealized gains (losses) on cash flow hedges:
|
|
|
|
|
|
|
|
||||||||
Unrealized cash flow hedge gains (losses) arising during the period
|
(650
|
)
|
|
(2,302
|
)
|
|
304
|
|
|
(4,647
|
)
|
||||
Net (gains) losses reclassified into income for revenue hedges
|
(825
|
)
|
|
1,131
|
|
|
(985
|
)
|
|
1,149
|
|
||||
Net (gains) losses reclassified into income for cost of revenue hedges
|
589
|
|
|
(174
|
)
|
|
1,316
|
|
|
(132
|
)
|
||||
Net unrealized gains (losses) on cash flow hedges
|
(886
|
)
|
|
(1,345
|
)
|
|
635
|
|
|
(3,630
|
)
|
||||
Unrealized gains (losses) on investments:
|
|
|
|
|
|
|
|
||||||||
Unrealized holding gains (losses) during the period
|
(272
|
)
|
|
133
|
|
|
42
|
|
|
209
|
|
||||
|
|
|
|
|
|
|
|
||||||||
Aggregate income tax benefit (expense) of the above items
|
98
|
|
|
(19
|
)
|
|
(26
|
)
|
|
1
|
|
||||
Other comprehensive income (loss)
|
(1,056
|
)
|
|
(1,174
|
)
|
|
401
|
|
|
(3,163
|
)
|
||||
Comprehensive income
|
$
|
19,418
|
|
|
$
|
18,779
|
|
|
$
|
41,262
|
|
|
$
|
35,618
|
|
|
Six Months Ended
|
||||||
|
September 30,
|
||||||
|
2016
|
|
2017
|
||||
CASH FLOWS FROM OPERATING ACTIVITIES
|
|
|
|
||||
Net income
|
$
|
40,861
|
|
|
$
|
38,781
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
10,265
|
|
|
10,743
|
|
||
Amortization of debt issuance costs
|
725
|
|
|
725
|
|
||
Stock-based compensation
|
16,316
|
|
|
18,018
|
|
||
Deferred income taxes
|
2,499
|
|
|
4,384
|
|
||
Provision for excess and obsolete inventories
|
1,674
|
|
|
900
|
|
||
Restructuring and related charges (credits)
|
(1,463
|
)
|
|
2,522
|
|
||
Cash payments for restructuring charges
|
(3,736
|
)
|
|
(2,429
|
)
|
||
Other operating activities
|
(849
|
)
|
|
(1,141
|
)
|
||
Changes in assets and liabilities:
|
|
|
|
|
|||
Accounts receivable, net
|
(8,366
|
)
|
|
1,246
|
|
||
Inventory, net
|
(1,102
|
)
|
|
(5,844
|
)
|
||
Current and other assets
|
(2,331
|
)
|
|
(4,539
|
)
|
||
Accounts payable
|
4,120
|
|
|
3,205
|
|
||
Accrued liabilities
|
10,444
|
|
|
(9,388
|
)
|
||
Income taxes
|
(2,305
|
)
|
|
(7,890
|
)
|
||
Cash provided by operating activities
|
66,752
|
|
|
49,293
|
|
||
CASH FLOWS FROM INVESTING ACTIVITIES
|
|
|
|
|
|||
Proceeds from sales of investments
|
125,504
|
|
|
30,895
|
|
||
Proceeds from maturities of investments
|
63,853
|
|
|
106,661
|
|
||
Purchase of investments
|
(192,349
|
)
|
|
(133,949
|
)
|
||
Capital expenditures
|
(14,191
|
)
|
|
(6,752
|
)
|
||
Cash used for investing activities
|
(17,183
|
)
|
|
(3,145
|
)
|
||
CASH FLOWS FROM FINANCING ACTIVITIES
|
|
|
|
|
|||
Repurchase of common stock
|
(26,828
|
)
|
|
(39,222
|
)
|
||
Employees' tax withheld and paid for restricted stock and restricted stock units
|
(9,123
|
)
|
|
(10,789
|
)
|
||
Proceeds from issuances under stock-based compensation plans
|
5,752
|
|
|
11,950
|
|
||
Payment of cash dividends
|
(9,971
|
)
|
|
(10,057
|
)
|
||
Other financing activity
|
761
|
|
|
—
|
|
||
Cash used for financing activities
|
(39,409
|
)
|
|
(48,118
|
)
|
||
Effect of exchange rate changes on cash and cash equivalents
|
(971
|
)
|
|
3,116
|
|
||
Net increase in cash and cash equivalents
|
9,189
|
|
|
1,146
|
|
||
Cash and cash equivalents at beginning of period
|
235,266
|
|
|
301,970
|
|
||
Cash and cash equivalents at end of period
|
$
|
244,455
|
|
|
$
|
303,116
|
|
SUPPLEMENTAL NON-CASH DISCLOSURES
|
|
|
|
||||
Accounts payable for purchases of property, plant, and equipment
|
$
|
2,718
|
|
|
$
|
3,407
|
|
•
|
Software Revenue: The Company currently defers revenue for the value of software where vendor specific objective evidence ("VSOE") of fair value has not been established for undelivered items. Under Topic 606, revenue for such licenses will be recognized at the transfer of control, rather than ratably, as the VSOE requirement no longer applies and the value of the remaining services are not material in the context of the contract. At June 30, 2017, deferred revenue under Topic 605 for these licenses was
$1.9 million
. The Company expects the remaining balance of such deferred revenue will be eliminated as a cumulative effect adjustment of implementing Topic 606 in the first quarter of its fiscal year ending March 31, 2019.
|
•
|
Marketing Development Funds: The Company frequently provides marketing development funds to its channel partners. Under topic 605, our marketing development funds are recognized as a reduction of revenue at the later of when the related revenue is recognized or when the program is offered to the channel partner. Applying the criteria of Topic 606, these marketing development programs qualify as variable consideration, and are assigned as a reduction of the transaction price of the contract. This results in a timing difference such that all or some of the funds related to a program may be recognized in different periods than under Topic 605, depending on the circumstances. Based on analysis of prior periods, we anticipate that this timing difference impacts revenue by immaterial amounts in a given period. The full impact of the adjustment is still being analyzed by the Company.
|
•
|
Revenue Reserves: The Company establishes reserves for Discounts and Rebates and Sales Returns at the end of each fiscal period. These reserves are estimated based on current relevant and historical data, but there can be some variability associated with unforeseen changes in customer claim and return patterns. Under Topic 606, in cases where there is uncertainty around the variable consideration amount, a constraint, or an adjustment to ensure that a significant revenue reversal will not occur, on that consideration must be considered. Based on analysis of prior periods, we anticipate that impact of introducing this constraint will not materially impact revenue. The full impact of the adjustment is still being analyzed by the Company.
|
September 30, 2017
|
|
Amortized
Cost |
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses |
|
Fair
Value |
|
Cash & Cash Equivalents
|
|
Short-term investments (due in 1 year or less)
|
|
Long-term investments (due in 1 to 3 years)
|
||||||||||||||
Cash
|
|
$
|
290,429
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
290,429
|
|
|
$
|
290,429
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Level 1:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Mutual Funds
|
|
13,507
|
|
|
675
|
|
|
(27
|
)
|
|
14,155
|
|
|
—
|
|
|
14,155
|
|
|
—
|
|
|||||||
US Treasury Notes
|
|
32,958
|
|
|
—
|
|
|
(66
|
)
|
|
32,892
|
|
|
—
|
|
|
20,084
|
|
|
12,808
|
|
|||||||
Subtotal
|
|
46,465
|
|
|
675
|
|
|
(93
|
)
|
|
47,047
|
|
|
—
|
|
|
34,239
|
|
|
12,808
|
|
|||||||
Level 2:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Government Agency Securities
|
|
47,851
|
|
|
—
|
|
|
(139
|
)
|
|
47,712
|
|
|
—
|
|
|
26,870
|
|
|
20,842
|
|
|||||||
Commercial Paper
|
|
52,099
|
|
|
—
|
|
|
—
|
|
|
52,099
|
|
|
11,185
|
|
|
40,914
|
|
|
—
|
|
|||||||
Corporate Bonds
|
|
146,781
|
|
|
126
|
|
|
(95
|
)
|
|
146,812
|
|
|
—
|
|
|
78,730
|
|
|
68,082
|
|
|||||||
Certificates of Deposits ("CDs")
|
|
21,532
|
|
|
14
|
|
|
—
|
|
|
21,546
|
|
|
1,502
|
|
|
16,525
|
|
|
3,519
|
|
|||||||
Subtotal
|
|
268,263
|
|
|
140
|
|
|
(234
|
)
|
|
268,169
|
|
|
12,687
|
|
|
163,039
|
|
|
92,443
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Total cash, cash equivalents
and investments measured at fair value |
|
$
|
605,157
|
|
|
$
|
815
|
|
|
$
|
(327
|
)
|
|
$
|
605,645
|
|
|
$
|
303,116
|
|
|
$
|
197,278
|
|
|
$
|
105,251
|
|
March 31, 2017
|
|
Amortized
Cost |
|
Gross
Unrealized Gains |
|
Gross
Unrealized Losses |
|
Fair
Value |
|
Cash & Cash Equivalents
|
|
Short-term investments (due in 1 year or less)
|
|
Long-term investments (due in 1 to 3 years)
|
||||||||||||||
Cash
|
|
$
|
295,877
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
295,877
|
|
|
$
|
295,877
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Level 1:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Mutual Funds
|
|
12,079
|
|
|
352
|
|
|
(32
|
)
|
|
12,399
|
|
|
—
|
|
|
12,399
|
|
|
—
|
|
|||||||
US Treasury Notes
|
|
35,960
|
|
|
—
|
|
|
(68
|
)
|
|
35,892
|
|
|
—
|
|
|
17,560
|
|
|
18,332
|
|
|||||||
Subtotal
|
|
48,039
|
|
|
352
|
|
|
(100
|
)
|
|
48,291
|
|
|
—
|
|
|
29,959
|
|
|
18,332
|
|
|||||||
Level 2:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Government Agency Securities
|
|
54,415
|
|
|
20
|
|
|
(164
|
)
|
|
54,271
|
|
|
—
|
|
|
15,309
|
|
|
38,962
|
|
|||||||
Commercial Paper
|
|
47,152
|
|
|
—
|
|
|
—
|
|
|
47,152
|
|
|
6,093
|
|
|
41,059
|
|
|
—
|
|
|||||||
Corporate Bonds
|
|
141,508
|
|
|
64
|
|
|
(224
|
)
|
|
141,348
|
|
|
—
|
|
|
73,676
|
|
|
67,672
|
|
|||||||
Certificates of Deposits ("CDs")
|
|
20,383
|
|
|
3
|
|
|
—
|
|
|
20,386
|
|
|
—
|
|
|
18,176
|
|
|
2,210
|
|
|||||||
Subtotal
|
|
263,458
|
|
|
87
|
|
|
(388
|
)
|
|
263,157
|
|
|
6,093
|
|
|
148,220
|
|
|
108,844
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||
Total cash, cash equivalents
and investments measured at fair value |
|
$
|
607,374
|
|
|
$
|
439
|
|
|
$
|
(488
|
)
|
|
$
|
607,325
|
|
|
$
|
301,970
|
|
|
$
|
178,179
|
|
|
$
|
127,176
|
|
|
|
March 31,
|
|
September 30,
|
||||
(in thousands)
|
|
2017
|
|
2017
|
||||
Accounts receivable
|
|
$
|
184,068
|
|
|
$
|
186,870
|
|
Provisions for returns
|
|
(10,541
|
)
|
|
(9,865
|
)
|
||
Provisions for promotions, rebates, and other
|
|
(31,747
|
)
|
|
(36,513
|
)
|
||
Provisions for doubtful accounts and sales allowances
|
|
(603
|
)
|
|
(809
|
)
|
||
Accounts receivable, net
|
|
$
|
141,177
|
|
|
$
|
139,683
|
|
|
|
March 31,
|
|
September 30,
|
||||
(in thousands)
|
|
2017
|
|
2017
|
||||
Raw materials
|
|
$
|
20,260
|
|
|
$
|
22,668
|
|
Work in process
|
|
215
|
|
|
237
|
|
||
Finished goods
|
|
34,981
|
|
|
38,094
|
|
||
Inventory, net
|
|
$
|
55,456
|
|
|
$
|
60,999
|
|
|
|
March 31,
|
|
September 30,
|
||||
(in thousands)
|
|
2017
|
|
2017
|
||||
Employee compensation and benefits
|
|
$
|
36,415
|
|
|
$
|
22,278
|
|
Accrued interest on 5.50% Senior Notes
|
|
10,407
|
|
|
10,312
|
|
||
Warranty obligation
|
|
6,863
|
|
|
6,739
|
|
||
VAT/Sales tax payable
|
|
5,433
|
|
|
5,852
|
|
||
Derivative liabilities
|
|
1,323
|
|
|
4,588
|
|
||
Accrued other
|
|
13,844
|
|
|
18,665
|
|
||
Accrued liabilities
|
|
$
|
74,285
|
|
|
$
|
68,434
|
|
|
|
Six Months Ended
September 30, |
||||||
(in thousands)
|
|
2016
|
|
2017
|
||||
Warranty obligation at beginning of period
|
|
$
|
8,537
|
|
|
$
|
8,697
|
|
Warranty provision related to products shipped
|
|
4,649
|
|
|
4,635
|
|
||
Deductions for warranty claims processed
|
|
(4,742
|
)
|
|
(5,080
|
)
|
||
Adjustments related to preexisting warranties
|
|
96
|
|
|
405
|
|
||
Warranty obligation at end of period
(1)
|
|
$
|
8,540
|
|
|
$
|
8,657
|
|
|
March 31, 2017
|
|
September 30, 2017
|
||||||||||||
(in thousands)
|
Fair Value
|
|
Carrying Value
|
|
Fair Value
|
|
Carrying Value
|
||||||||
5.50% Senior Notes
|
$
|
505,150
|
|
|
$
|
491,059
|
|
|
$
|
520,205
|
|
|
$
|
491,784
|
|
|
Six months ended September 30, 2017
|
|||||||||||
(in millions)
|
Total Charges
|
Restructuring and Other Related Charges (Credits)
|
Cost of Revenues
|
Selling, General, and Administrative
|
||||||||
Severance benefits from reduction-in-force
|
$
|
1.4
|
|
$
|
1.4
|
|
$
|
—
|
|
$
|
—
|
|
Lease exit charge and asset impairments in Netherlands
|
0.7
|
|
0.7
|
|
—
|
|
—
|
|
||||
Write-off of unrecoverable indirect tax asset in Brazil
|
0.7
|
|
—
|
|
0.7
|
|
—
|
|
||||
Asset impairments related to previous Clarity operations
|
0.4
|
|
0.4
|
|
—
|
|
—
|
|
||||
Loss on Clarity asset sale
|
0.9
|
|
—
|
|
0.9
|
|
—
|
|
||||
Accelerated vesting of restricted stock
|
0.2
|
|
—
|
|
—
|
|
0.2
|
|
||||
Totals
|
$
|
4.3
|
|
$
|
2.5
|
|
$
|
1.6
|
|
$
|
0.2
|
|
|
|
Three Months Ended
September 30, |
|
Six Months Ended
September 30, |
||||||||||||
(in thousands)
|
|
2016
|
|
2017
|
|
2016
|
|
2017
|
||||||||
Cost of revenues
|
|
$
|
778
|
|
|
$
|
890
|
|
|
$
|
1,620
|
|
|
$
|
1,792
|
|
|
|
|
|
|
|
|
|
|
||||||||
Research, development, and engineering
|
|
2,408
|
|
|
2,008
|
|
|
4,892
|
|
|
4,109
|
|
||||
Selling, general, and administrative
|
|
4,717
|
|
|
5,864
|
|
|
9,804
|
|
|
12,117
|
|
||||
Stock-based compensation included in operating expenses
|
|
7,125
|
|
|
7,872
|
|
|
14,696
|
|
|
16,226
|
|
||||
Total stock-based compensation
|
|
7,903
|
|
|
8,762
|
|
|
16,316
|
|
|
18,018
|
|
||||
Income tax benefit
|
|
(2,877
|
)
|
|
(2,840
|
)
|
|
(5,649
|
)
|
|
(7,689
|
)
|
||||
Total stock-based compensation, net of tax
|
|
$
|
5,026
|
|
|
$
|
5,922
|
|
|
$
|
10,667
|
|
|
$
|
10,329
|
|
(in thousands)
|
|
March 31, 2017
|
|
September 30, 2017
|
|||||
Accumulated unrealized gain (loss) on cash flow hedges
(1)
|
|
$
|
529
|
|
|
$
|
(3,039
|
)
|
|
Accumulated foreign currency translation adjustments
|
|
4,428
|
|
|
4,685
|
|
|||
Accumulated unrealized gain (loss) on investments
|
|
(263
|
)
|
|
(115
|
)
|
|||
Accumulated other comprehensive income
|
|
$
|
4,694
|
|
|
$
|
1,531
|
|
(in thousands)
|
|
March 31, 2017
|
|
September 30, 2017
|
||||
Derivative Assets
(1)
|
|
|
|
|
||||
Non-designated hedges
|
|
$
|
86
|
|
|
$
|
310
|
|
Cash flow hedges
|
|
2,034
|
|
|
505
|
|
||
Total Derivative Assets
|
|
$
|
2,120
|
|
|
$
|
815
|
|
|
|
|
|
|
||||
Derivative Liabilities
(2)
|
|
|
|
|
||||
Non-designated hedges
|
|
$
|
286
|
|
|
$
|
339
|
|
Cash flow hedges
|
|
1,109
|
|
|
4,346
|
|
||
Total Derivative Liabilities
|
|
$
|
1,395
|
|
|
$
|
4,685
|
|
(in thousands)
|
Local Currency
|
|
USD Equivalent
|
|
Position
|
|
Maturity
|
||||
EUR
|
€
|
33,900
|
|
|
$
|
28,650
|
|
|
Sell EUR
|
|
1 month
|
GBP
|
£
|
5,000
|
|
|
$
|
6,710
|
|
|
Sell GBP
|
|
1 month
|
AUD
|
A$
|
13,200
|
|
|
$
|
10,352
|
|
|
Sell AUD
|
|
1 month
|
CAD
|
C$
|
2,700
|
|
|
$
|
2,161
|
|
|
Sell CAD
|
|
1 month
|
|
|
Three Months Ended
September 30, |
|
Six Months Ended
September 30, |
||||||||||||
(in thousands)
|
|
2016
|
|
2017
|
|
2016
|
|
2017
|
||||||||
Gain (loss) on foreign exchange contracts
|
|
$
|
(193
|
)
|
|
$
|
2,102
|
|
|
$
|
1,750
|
|
|
$
|
5,236
|
|
|
|
March 31, 2017
|
|
September 30, 2017
|
||||
(in millions)
|
|
EUR
|
|
GBP
|
|
EUR
|
|
GBP
|
Option contracts
|
|
€73.5
|
|
£23.9
|
|
€81.7
|
|
£23.9
|
Forward contracts
|
|
€11.2
|
|
£3.3
|
|
€13.4
|
|
£3.6
|
(in thousands)
|
Local Currency
|
|
USD Equivalent
|
|
Position
|
|
Maturity
|
|||||
MXN
|
$
|
134,150
|
|
|
$
|
6,978
|
|
|
Buy MXN
|
|
Monthly over
|
9 months
|
|
|
Three Months Ended
September 30, |
|
Six Months Ended
September 30, |
||||||||||||
(in thousands)
|
|
2016
|
|
2017
|
|
2016
|
|
2017
|
||||||||
Gain (loss) included in AOCI as of beginning of period
|
|
$
|
415
|
|
|
$
|
(1,744
|
)
|
|
$
|
(1,106
|
)
|
|
$
|
541
|
|
|
|
|
|
|
|
|
|
|
||||||||
Amount of gain (loss) recognized in other comprehensive income (“OCI”)
(effective portion)
|
|
(650
|
)
|
|
(2,302
|
)
|
|
304
|
|
|
(4,647
|
)
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Amount of gain (loss) reclassified from OCI into net revenues (effective portion)
|
|
825
|
|
|
1,131
|
|
|
985
|
|
|
1,149
|
|
||||
Amount of gain (loss) reclassified from OCI into cost of revenues (effective portion)
|
|
(589
|
)
|
|
(174
|
)
|
|
(1,316
|
)
|
|
(132
|
)
|
||||
Total amount of gain (loss) reclassified from AOCI to income (loss) (effective portion)
|
|
236
|
|
|
957
|
|
|
(331
|
)
|
|
1,017
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Gain (loss) included in AOCI as of end of period
|
|
$
|
(471
|
)
|
|
$
|
(3,089
|
)
|
|
$
|
(471
|
)
|
|
$
|
(3,089
|
)
|
|
|
Three Months Ended
September 30, |
|
Six Months Ended
September 30, |
||||||||||||
(in thousands, except per share data)
|
|
2016
(1)
|
|
2017
|
|
2016
(1)
|
|
2017
|
||||||||
Basic earnings per common share:
|
|
|
|
|
|
|
|
|
||||||||
Numerator:
|
|
|
|
|
|
|
|
|
||||||||
Net income
|
|
$
|
20,474
|
|
|
$
|
19,953
|
|
|
$
|
40,861
|
|
|
$
|
38,781
|
|
Income allocated to participating securities, basic
|
|
n/a
|
|
|
(597
|
)
|
|
n/a
|
|
|
(1,169
|
)
|
||||
Net income attributable to common shareholders, basic
|
|
$
|
20,474
|
|
|
$
|
19,356
|
|
|
$
|
40,861
|
|
|
$
|
37,612
|
|
|
|
|
|
|
|
|
|
|
||||||||
Denominator:
|
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares, basic
|
|
32,281
|
|
|
32,570
|
|
|
32,269
|
|
|
32,538
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Basic earnings per common share
|
|
$
|
0.63
|
|
|
$
|
0.59
|
|
|
$
|
1.27
|
|
|
$
|
1.16
|
|
|
|
|
|
|
|
|
|
|
||||||||
Diluted earnings per common share:
|
|
|
|
|
|
|
|
|
||||||||
Numerator:
|
|
|
|
|
|
|
|
|
||||||||
Net income attributable to common shareholders, basic
|
|
$
|
20,474
|
|
|
$
|
19,356
|
|
|
$
|
40,861
|
|
|
$
|
37,612
|
|
Net effect of reallocating undistributed earnings of unvested shareholders
|
|
n/a
|
|
|
3
|
|
|
n/a
|
|
|
15
|
|
||||
Net income attributable to common shareholders, diluted
|
|
$
|
20,474
|
|
|
$
|
19,359
|
|
|
$
|
40,861
|
|
|
$
|
37,627
|
|
|
|
|
|
|
|
|
|
|
||||||||
Denominator:
|
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares-basic
|
|
32,281
|
|
|
32,570
|
|
|
32,269
|
|
|
32,538
|
|
||||
Dilutive effect of employee equity incentive plans
|
|
445
|
|
|
239
|
|
|
596
|
|
|
573
|
|
||||
Weighted average common shares, diluted
|
|
32,726
|
|
|
32,809
|
|
|
32,865
|
|
|
33,111
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Diluted earnings per common share
|
|
$
|
0.63
|
|
|
$
|
0.59
|
|
|
$
|
1.24
|
|
|
$
|
1.14
|
|
|
|
|
|
|
|
|
|
|
||||||||
Potentially dilutive securities excluded from diluted earnings per common share because their effect is anti-dilutive
|
|
543
|
|
|
1,389
|
|
|
634
|
|
|
959
|
|
|
|
Three Months Ended
September 30, |
|
Six Months Ended
September 30, |
||||||||||||
(in thousands)
|
|
2016
|
|
2017
|
|
2016
|
|
2017
|
||||||||
Net revenues from unaffiliated customers:
|
|
|
|
|
|
|
|
|
||||||||
Enterprise
|
|
$
|
154,542
|
|
|
$
|
162,907
|
|
|
$
|
310,439
|
|
|
$
|
317,512
|
|
Consumer
|
|
61,641
|
|
|
47,393
|
|
|
128,850
|
|
|
96,714
|
|
||||
Total net revenues
|
|
$
|
216,183
|
|
|
$
|
210,300
|
|
|
$
|
439,289
|
|
|
$
|
414,226
|
|
|
|
Three Months Ended
September 30, |
|
Six Months Ended
September 30, |
||||||||||||
(in thousands)
|
|
2016
|
|
2017
|
|
2016
|
|
2017
|
||||||||
Net revenues from unaffiliated customers:
|
|
|
|
|
|
|
|
|
||||||||
U.S.
|
|
$
|
119,062
|
|
|
$
|
111,095
|
|
|
$
|
247,300
|
|
|
$
|
219,905
|
|
|
|
|
|
|
|
|
|
|
||||||||
Europe and Africa
|
|
51,422
|
|
|
56,325
|
|
|
105,489
|
|
|
111,141
|
|
||||
Asia Pacific
|
|
28,588
|
|
|
24,227
|
|
|
54,815
|
|
|
48,111
|
|
||||
Americas, excluding U.S.
|
|
17,111
|
|
|
18,653
|
|
|
31,685
|
|
|
35,069
|
|
||||
Total international net revenues
|
|
97,121
|
|
|
99,205
|
|
|
191,989
|
|
|
194,321
|
|
||||
Total net revenues
|
|
$
|
216,183
|
|
|
$
|
210,300
|
|
|
$
|
439,289
|
|
|
$
|
414,226
|
|
(in millions)
|
|
March 31, 2017
|
|
September 30, 2017
|
||||
Cash and cash equivalents
|
|
$
|
302.0
|
|
|
$
|
303.1
|
|
Short-term investments
|
|
$
|
178.2
|
|
|
$
|
197.3
|
|
Long-term investments
|
|
$
|
127.2
|
|
|
$
|
105.3
|
|
Currency - forward contracts
|
Position
|
|
USD Value of Net Foreign Exchange Contracts
|
|
Foreign Exchange Gain From 10% Appreciation of USD
|
|
Foreign Exchange Loss From 10% Depreciation of USD
|
||||||
EUR
|
Sell EUR
|
|
$
|
28.7
|
|
|
$
|
3.4
|
|
|
$
|
(3.4
|
)
|
GBP
|
Sell GBP
|
|
$
|
6.7
|
|
|
$
|
0.7
|
|
|
$
|
(0.7
|
)
|
AUD
|
Sell AUD
|
|
$
|
10.4
|
|
|
$
|
1.0
|
|
|
$
|
(1.0
|
)
|
CAD
|
Sell CAD
|
|
$
|
2.2
|
|
|
$
|
0.2
|
|
|
$
|
(0.2
|
)
|
Currency - option contracts
|
USD Value of Net Foreign Exchange Contracts
|
|
Foreign Exchange Gain From 10% Appreciation of USD
|
|
Foreign Exchange Loss From 10% Depreciation of USD
|
||||||
Call options
|
$
|
127.5
|
|
|
$
|
6.0
|
|
|
$
|
(10.1
|
)
|
Put options
|
$
|
117.5
|
|
|
$
|
2.5
|
|
|
$
|
(0.4
|
)
|
Forwards
|
$
|
20.2
|
|
|
$
|
2.1
|
|
|
$
|
(2.0
|
)
|
Currency - cross-currency swap contracts
|
Position
|
USD Value of Net Foreign Exchange Contracts
|
|
Foreign Exchange Loss From 10% Appreciation of USD
|
|
Foreign Exchange Gain From 10% Depreciation of USD
|
||||||
MXN
|
Buy MXN
|
$
|
7.0
|
|
|
$
|
(0.9
|
)
|
|
$
|
0.5
|
|
(a)
|
Evaluation of disclosure controls and procedures
|
(b)
|
Changes in internal control over financial reporting
|
|
Total Number of Shares Purchased
1
|
|
Average Price Paid per Share
2
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
1
|
|
Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs
6
|
|||||
July 2, 2017 to July 28, 2017
|
11,024
|
|
3
|
$
|
51.51
|
|
|
7,776
|
|
|
1,609,352
|
|
July 29, 2017 to August 25, 2017
|
305,380
|
|
4
|
$
|
44.30
|
|
|
304,262
|
|
|
1,305,090
|
|
August 26, 2017 to September 30, 2017
|
278,426
|
|
5
|
$
|
42.86
|
|
|
276,504
|
|
|
1,028,586
|
|
1
|
|
On July 29, 2016 and July 27, 2017, respectively, the Board of Directors authorized programs to repurchase 1,000,000 shares of our common stock from time to time in the market or in privately negotiated repurchases as determined by management.
|
|
|
|
2
|
|
"Average Price Paid per Share" reflects open market repurchases of common stock only.
|
|
|
|
3
|
|
Includ
es
3,248 s
hares
that were tendered to us in satisfaction of employee tax withholding obligations upon the vesting of restricted stock granted under our stock plans.
|
|
|
|
4
|
|
Includes 1,118 s
hares
that were tendered to us in satisfaction of employee tax withholding obligations upon the vesting of restricted stock granted under our stock plans.
|
|
|
|
5
|
|
Includes 1,922 sh
ares
that were tendered to us in satisfaction of employee tax withholding obligations upon the vesting of restricted stock granted under our stock plans.
|
|
|
|
6
|
|
These shares reflect the available shares authorized for repurchase under the programs approved by the Board on July 29, 2016 and July 27, 2017.
|
Exhibit Number
|
|
|
|
Incorporation by Reference
|
|
Filed Herewith
|
||||||
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8-K
|
|
001-12696
|
|
10.1
|
|
8/4/2017
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8-K
|
|
001-12696
|
|
10.2
|
|
8/4/2017
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
X
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PLANTRONICS, INC.
|
|
|
|
|
|
Date:
|
October 31, 2017
|
By:
|
/s/ Pamela Strayer
|
|
|
Name:
|
Pamela Strayer
|
|
|
Title:
|
Senior Vice President and Chief Financial Officer
|
1.
|
Employment Status
:
Your employment will end on July 17, 2017 (“
Separation Date
”). On the Separation Date you will be paid all of your wages earned, but unpaid, through the Separation Date. Your health insurance benefits will continue until the end of the month in which your Separation Date occurs, subject to any right to continue your health insurance coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“
COBRA
”). All other benefits will cease on Separation Date.
|
2.
|
Consideration
:
In exchange for, and in consideration of, your full execution and return of this Agreement within 21 days from the date of this letter, and provided that you do not revoke the Agreement under Section 6(d) below, the Company agrees as follows:
|
3.
|
Government Agency Claims
:
Nothing in this Agreement, including the Release, Nondisparagement or Confidentiality provisions, restricts or prohibits you from initiating communications directly with, responding to any inquiries from, providing testimony before, providing confidential information to, reporting possible violations of law or regulation to, or from filing a claim or assisting with an investigation directly with a self-regulatory authority or a government agency or entity, including the U.S. Equal Employment Opportunity Commission, the Department of Labor, the National Labor Relations Board, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General (collectively, the “
Regulators
”), or from making other disclosures that are protected under the whistleblower provisions of state or federal law or regulation. However, to the maximum extent permitted by law, you are waiving your right to receive any individual monetary relief from the Company or any others covered by the Release resulting from such claims or conduct, regardless of whether you or another party has filed them, and in the event you obtain such monetary relief the Company will be entitled to an offset for the payments made pursuant to this Agreement. This Agreement does not limit your right to receive an award from any Regulator that provides awards for providing information relating to a potential violation of law. You do not need the prior authorization of the Company to engage in conduct protected by this paragraph, and you do not need to notify the Company that you have engaged in such conduct. Please take notice that federal law provides criminal and civil immunity to federal and state claims for
|
4.
|
Release
:
|
(i)
|
Unemployment benefits pursuant to the terms of applicable law (to the extent available to you under applicable law);
|
(ii)
|
Workers’ compensation insurance benefits pursuant to Division 4 of the California Labor Code or a comparable and applicable state law, under the terms of any workers’ compensation insurance policy or fund of the Company(for which you represent that you have reported all work-related injuries, if any, that you have suffered or sustained during your employment with the company);
|
(iii)
|
Continued participation in certain of the Company’s medical, dental, vision health benefit plans pursuant to the terms and conditions of COBRA, if applicable, and/or any applicable state law counterpart to COBRA;
|
(iv)
|
Any benefit entitlements vested as of your Separation Date, pursuant to written terms of any applicable employee benefit plan sponsored by the Company; and
|
(v)
|
Any claims that, as a matter of applicable law, are not waivable.
|
5.
|
Full Payment
:
The amounts set forth above in Section 2 shall be complete and unconditional payment, settlement, accord and/or satisfaction with respect to all obligations and liabilities of the Company Releasees to you, including, without limitation, all claims for disputed compensation or benefits, including bonuses, stock and stock options, commissions, severance pay, reimbursement of expenses or other costs or sums.
|
6.
|
Waiver of Rights and Claims Under the Age Discrimination in Employment Act of 1967
:
|
7.
|
Company Files, Documents and Other Property
:
You agree that on or before the Separation Date you will return to the Company all Company property and materials, including but not limited to (if applicable), personal computers, laptops, fax machines, scanners, copiers, cellular phones, Company credit cards and telephone charge cards, manuals, building keys and passes, courtesy parking passes, diskettes, intangible information stored on diskettes, software programs and data compiled with the use of those programs, software passwords or codes, tangible copies of trade secrets and confidential information, sales forecasts, names and addresses of Company customers and potential customers, customer lists, customer contacts, sales information, sales forecasts, memoranda, sales brochures, business or marketing plans, reports, projections, and any and all other information or property previously or currently held or used by you that is or was related to your employment with the Company (“
Company Property
”). You agree that in the event that you discover any other Company Property in your possession after your Separation Date, you will immediately return such materials to the Company.
|
8.
|
Final Expense Reimbursement Request
:
You agree that on or before July 11, 2017 you will submit to the Company all final requests for reimbursement of any business expenses you were required to incur in performing your job for the Company prior to that date. You understand and agree that all such reimbursements will be subject to the terms and conditions of the Company’s then current Travel and Expense Reimbursement policy and other applicable policies and procedures.
|
9.
|
Nondisparagement
:
Except as described in Section 3, and not including any testimony given truthfully under oath or as required by any other legal proceeding, you agree not to make disparaging, critical or otherwise detrimental comments to any person or entity concerning the Company, its officers, directors or employees; the products, services or programs provided or to be provided by the Company; the business affairs, operation, management or the financial condition of the Company; or the circumstances surrounding your employment and/or separation of employment from the Company. The Company’s officers and directors agree to mutual non-disparagement terms.
|
10.
|
Equity
:
To the extent that you hold any Company equity awards, such as stock options or restricted stock units or any underlying shares of Company stock, these equity awards remain subject to the terms and conditions of the applicable agreement(s) signed by you and the terms and conditions of the Company’s 2003 Stock Plan (“
Equity Agreements
”).
|
11.
|
Stock Trading
:
You may continue to sell vested restricted stock shares or ESPP shares through your E*Trade account at www.etrade.com/stockplans. If you need phone assistance with your transaction, you may reach E*Trade at (800) 838-0908 or (650) 599-0125. If you do not need preclearance to sell shares, you may sell any time after your termination as long as you are not in possession of material non-public information about the Company. The rest of this Section 11 does not apply to you. If you require pre-clearance to sell PLT Stock, you should continue to obtain pre-clearance for 3 months after your last day of employment. You may sell during open window periods as long as you are not in possession of material non-public information during the open window periods. You may not sell during our closed windows during this 3 month time period. After the 3 months expires, you may sell during any open or closed window period as long as you are not in possession of material non-public information.
|
12.
|
Prior Agreement
:
You understand and agree that you have continuing obligations under the Employee Patent, Secrecy and Invention Agreement (EPSIA) and any other agreements you have with the Company. You reaffirm your commitment under the EPSIA in this Agreement, and agree that, as part of this Agreement, you will comply fully with the terms of the EPSIA. This includes, but is not limited to, your express agreement not to use or disclose any of the Company’s confidential, proprietary, or trade secret information following your Separation Date, with your acknowledgment that all such information (including but not limited to proprietary information regarding the Company’s past, present, and prospective customers, customer contact information, pipeline data, and markets) belongs to the Company in accordance with the EPSIA. You also confirm that you have not violated the EPSIA.
|
13.
|
Non-Solicitation
:
For a period of twelve (12) months immediately following the Separation Date, you agree that you shall not, directly or indirectly, solicit any of the Company's employees to terminate their employment with the Company.
|
14.
|
Confidentiality
:
Except as described in Section 3, you agree that you will not disclose to others the fact or terms of this Agreement, except that you may disclose such information to your attorney or accountant in order for such individuals to render services to you.
|
15.
|
Cooperation
:
Except as described in Section 3, you agree to make yourself reasonably available to the Company to respond to requests by the Company for information pertaining to or relating to the Company and/or its subsidiaries, affiliates, partners, directors, officers, agents or employees that may be within your knowledge. Moreover, you agree to cooperate fully with the Company in connection with any and all existing or future litigation or investigations brought by or against the Company or any of its subsidiaries, affiliates, partners, directors, officers, agents or employees, whether administrative, civil or criminal in nature, in which and to the extent the Company deems your cooperation necessary.
|
16.
|
No Filing of Claims
:
You represent and warrant that you do not presently have on file any claims, charges, grievances, actions, appeals or complaints against Company Releasees in or with any administrative, state, federal or governmental entity, agency, board or court, or before any other tribunal or arbitrator(s), public or private, based upon any actions occurring prior to the date of this Agreement.
|
18.
|
Unemployment Application
:
The Company agrees it does not plan to opposed an unemployment application related to employment with the Company.
|
19.
|
Certain Covenants and Representations; Governing Law
:
|
401(k)
|
You are eligible to join the Plantronics, Inc. 401(k). You automatically become a participant for purposes of the discretionary employer contribution as soon as you receive your first pay check from Plantronics. Plantronics, Inc. makes a discretionary employer contribution of 3% of your base salary on a bi-weekly basis to the 401(k). You may also contribute, as pre-tax or Roth contributions, between 1% and 50% of your eligible compensation each pay period, up to the annual IRS maximum ($18,000 in 2017) once you have enrolled. If you are over age 50 or will be turning 50 in this calendar year you may also contribute an additional ”catch up contribution” amount ($6,000 for 2017) up to the annual IRS maximum ($24,000 in 2017). You may enroll by calling the MassMutual FLASH Line at (800) 74FLASH (35274) or by visiting www.massmutual.com/retire/ and proceeding to The Journey link. Plantronics will match 50 cents for every $1.00 you contribute up to a maximum of 6% of your eligible compensation each pay period. The matching contribution is 100% vested immediately. If after 45 days from your date of hire you have not actively selected a contribution amount to set aside each pay period, Plantronics will automatically enroll you at a discretionary employee contribution of 3% of your eligible earnings on a bi-weekly basis to the 401(k). Please note that if you are classified as a part-time employee, you must be regularly scheduled to work at least twenty (20) hours per week to participate (if you are regularly scheduled to work less than 20 hours you will be eligible to participate when you actually work 1,000 hours in a year).
|
|
Non-Qualified Deferred Compensation Plan
|
You may be eligible to participate in a non-qualified deferred compensation plan, subject to the terms and conditions of the Plan Document. An eligible participant may elect to defer prospective compensation not yet earned by submitting a Compensation Deferral Agreement during the enrollment periods. Under the terms of the current plan, you may elect to defer up to 100% of your base salary (subject to limitation in order to meet FICA withholding and Section 125 deduction requirements on all W-2 compensation), up to 100% of your bonus earned during the coming year and paid the following year, and/or up to 100% of your eligible commissions. For more information regarding the Plantronics, Inc. Deferred Compensation Plan, please see the Prospectus.
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Plantronics, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
October 31, 2017
|
|
|
/s/ Joe Burton
|
|
Joe Burton
|
|
President, Chief Executive Officer and Director
|
1.
|
I have reviewed this quarterly report on Form 10-Q of Plantronics, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
October 31, 2017
|
|
|
/s/ Pamela Strayer
|
|
Pamela Strayer
|
|
Senior Vice President and Chief Financial Officer
|
|
By:
|
/s/ Joe Burton
|
|
Name:
|
Joe Burton
|
|
Title:
|
President, Chief Executive Officer and Director
|
|
Date:
|
October 31, 2017
|
|
By:
|
/s/ Pamela Strayer
|
|
Name:
|
Pamela Strayer
|
|
Title:
|
Senior Vice President and Chief Financial Officer
|
|
Date:
|
October 31, 2017
|